NSE: ARTEMISMED · BSE: 542919 · ISIN INE025R01021
Artemis Medicare Services Limited stock analysis
Artemis Medicare Services Limited ranks #598 in the TickerSutra evidence-ranked universe with a score of 62/100 and 95% data confidence. The latest captured fundamentals show ROCE of 14.5%, quarterly sales growth of 12.9% and quarterly profit growth of 45.0%.Monitor only
INVESTMENT EVIDENCE
What supports—and challenges—the thesis
Evidence in favour
- Low debt/equity of 0.28×
- Institutional ownership is rising
- CWIP indicates an active capacity pipeline
- No promoter shares are reported as pledged
Risks and constraints
- Valuation is above 40× earnings
Still unresolved: Related-party exposure · Broad media sentiment
FINANCIAL TRAJECTORY
Recent operating history
| Period | Revenue | Operating profit | Net profit | Operating margin |
|---|---|---|---|---|
| 2022 | ₹545cr | ₹68cr | ₹33cr | 12.0% |
| 2023 | ₹714cr | ₹94cr | ₹40cr | 13.0% |
| 2024 | ₹845cr | ₹128cr | ₹49cr | 15.0% |
| 2025 | ₹913cr | ₹150cr | ₹83cr | 16.0% |
| 2026 | ₹1,060cr | ₹185cr | ₹103cr | 17.0% |
| TTM | ₹1,093cr | ₹200cr | ₹113cr | 18.0% |
EXCHANGE EVENT TRIGGERS
Latest corporate disclosures
MANAGEMENT COMMENTARY
Signals from filed documents
HOW TO READ THIS PAGE
Evidence, freshness and limitations
What does the TickerSutra score mean?
The score ranks captured evidence across financial quality, growth, moat and margins, regulatory catalysts, governance, institutional trend and valuation comfort. It is a research-prioritization tool—not a buy recommendation or price target.
Which sources support this page?
Financial history, ownership and pledge data, NSE and BSE filings, annual reports and available earnings-call transcripts are combined here. Use the source trail and original exchange document before relying on a decision-critical fact.
Why can an item be unresolved?
Unresolved means the current captured source window did not provide enough evidence for that check. It does not establish that a risk or relationship is absent.
Maintained by TickerSutra Research · Snapshot updated 29 Sept 2026 · Read the methodology · Read the disclaimer
DIRECTOR & BUSINESS NETWORK
Loading corporate intelligence
Loading universe coverage and exchange-backed evidence…